ATE184703T1 - Verfahren und testsatz zur messung von endogenen zytokinen - Google Patents

Verfahren und testsatz zur messung von endogenen zytokinen

Info

Publication number
ATE184703T1
ATE184703T1 AT92916088T AT92916088T ATE184703T1 AT E184703 T1 ATE184703 T1 AT E184703T1 AT 92916088 T AT92916088 T AT 92916088T AT 92916088 T AT92916088 T AT 92916088T AT E184703 T1 ATE184703 T1 AT E184703T1
Authority
AT
Austria
Prior art keywords
cytokines
measuring
present
endogene
blood
Prior art date
Application number
AT92916088T
Other languages
English (en)
Inventor
Lawrence Tamarkin
Giulio F Paciotti
Original Assignee
Cytimmune Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytimmune Sciences Inc filed Critical Cytimmune Sciences Inc
Application granted granted Critical
Publication of ATE184703T1 publication Critical patent/ATE184703T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT92916088T 1991-07-19 1992-07-17 Verfahren und testsatz zur messung von endogenen zytokinen ATE184703T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73286791A 1991-07-19 1991-07-19
US85510992A 1992-03-20 1992-03-20

Publications (1)

Publication Number Publication Date
ATE184703T1 true ATE184703T1 (de) 1999-10-15

Family

ID=27112472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92916088T ATE184703T1 (de) 1991-07-19 1992-07-17 Verfahren und testsatz zur messung von endogenen zytokinen

Country Status (8)

Country Link
US (1) US5587294A (de)
EP (1) EP0598758B1 (de)
JP (1) JP3183666B2 (de)
AT (1) ATE184703T1 (de)
AU (1) AU2392692A (de)
CA (1) CA2113823A1 (de)
DE (1) DE69230000T2 (de)
WO (1) WO1993002359A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965379A (en) * 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
US6673621B1 (en) * 1996-10-04 2004-01-06 Intronn Llc Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation
ES2401121T3 (es) * 1996-10-04 2013-04-17 Veri-Q Inc. Dispositivos de recolección de muestras y métodos que utilizan marcadores y el uso de dichos marcadores como controles en la validación de una muestra, evaluación y/o certificación de laboratorio
US6824986B1 (en) 1997-10-06 2004-11-30 University Of Cincinnati Methods for measuring in vivo cytokine production
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
JP2004511807A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中のｒｓウイルスに関連した生物学的細胞の直接的検出のためのアッセイ
US20040048274A1 (en) * 2000-10-17 2004-03-11 Morten Breindahl Assay for directly detecting an inflammatory indicator in a body fluid sample
US20040063160A1 (en) * 2000-10-17 2004-04-01 Lassen Michael Rud Assay for directly detecting a biological cell in a body fluid sample
EP1354206A2 (de) * 2000-12-13 2003-10-22 Bio-Rad Laboratories, Inc. Standard-verdünnungsmittel für multiplex-bestimmungen
WO2004112691A2 (en) * 2003-05-19 2004-12-29 Intermune, Inc. Interferon gamma therapies for idiopathic pulmonary fibrosis
US20060094056A1 (en) 2003-09-15 2006-05-04 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
US20070150203A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A kit for assessing the pro-inflammatory immune health of an individual
US20070150202A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A method for assessing the efficacy of a program to improve or maitain the pro-inflammatory immune health
US20070150310A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A method of motivating an individual to improve lifestyle factors
US20070150205A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand Methods for assessing the pro-inflammatory immune health of an individual
US20070150204A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand Methods for recommending a program to improve or maintain pro-inflammatory immune health
DK2996808T3 (da) * 2013-05-14 2020-02-24 Fibrotx Oue Lateral flow assay-indretning
WO2020241809A1 (ja) * 2019-05-31 2020-12-03 日本たばこ産業株式会社 幸福感の評価方法及び幸福感を評価するためのデータ取得方法
WO2022038469A1 (en) * 2020-08-17 2022-02-24 Rjs Mediagnostix Fluid testing device

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) * 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
USRE32696E (en) * 1975-09-04 1988-06-14 Akzona Incorporated Enzymatic immunological method for determination of antigens and antibodies
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4020151A (en) * 1976-02-17 1977-04-26 International Diagnostic Technology, Inc. Method for quantitation of antigens or antibodies on a solid surface
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
US4271140A (en) * 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
AU8594382A (en) * 1981-08-05 1983-02-10 F. Hoffmann-La Roche Ag Immunoassay using biotin-avidin-enzyme complex
DE3377531D1 (en) * 1982-09-29 1988-09-01 Serono Diagnostics Ltd Immunoassay of antigens
US4496654A (en) * 1983-04-08 1985-01-29 Quidel Detection of HCG with solid phase support having avidin coating
US4798207A (en) * 1983-05-09 1989-01-17 Wade Stephen E Device for enabling time-integrated measurement of substances in biological fluids
US4594326A (en) * 1983-05-09 1986-06-10 Wade Stephen E Time-integrated measurement for determining substances in biological fluids
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
ZA872784B (en) * 1986-05-01 1987-10-16 Immunex Corporation Detection of inflammation and novel antibodies therefor
US4863726A (en) * 1987-05-29 1989-09-05 Cetus Corporation Combination therapy using immunotoxins with interleukin-2

Also Published As

Publication number Publication date
EP0598758A4 (de) 1995-02-01
JPH06509418A (ja) 1994-10-20
US5587294A (en) 1996-12-24
DE69230000D1 (de) 1999-10-21
JP3183666B2 (ja) 2001-07-09
EP0598758B1 (de) 1999-09-15
EP0598758A1 (de) 1994-06-01
CA2113823A1 (en) 1993-02-04
DE69230000T2 (de) 2000-05-11
WO1993002359A1 (en) 1993-02-04
AU2392692A (en) 1993-02-23

Similar Documents

Publication Publication Date Title
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE69333144D1 (de) Verfahren zur Identifizierung von Hemmstoffe der Produktion des beta-Amyloidpeptids
DE69016428D1 (de) Vorrichtung und verfahren zur bestimmung eines bestandteiles in einer flüssigkeitsprobe.
DE60011274D1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
DE50209636D1 (de) Messvorrichtung und -verfahren zur Bestimmung von Parametern medizinischer Flüssigkeiten
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
DE69713595D1 (de) Vorrichtung zur blutstrommessungsmittelsanalyse der biologischen impedanz
ATE157123T1 (de) Verfahren und vorrichtung zur amperometrischen diagnostischen analyse
DE69637244D1 (de) Verfahren zur nicht-invasiven messung eines blutwertes mit hilfe einer verbesserten optischen schnittstelle
ATE274868T1 (de) Diagnosegerät zur bestimmung der remineralisierbarkeit von hartgewebe
DE69920940D1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
ATE100150T1 (de) Verfahren zur bestimmung von physiologisch wirksamen substanzen.
DE68920769D1 (de) Gerät zur Messung der Geschwindigkeit von Organen und der Blutströmung durch Korrelationsverfahren.
DE69431016D1 (de) Verfahren zur "In-vivo"-Messung der Konzentration von xenobiotischen Verbindungen mittels magnetischer Kernresonanz
ATE145805T1 (de) Vorrichtung und verfahren zur ermittlung des herzzeitvolumens
DE3767042D1 (de) Messvorrichtung zur intrakardialen erfassung der blutsauerstoffsaettigung.
ATE529743T1 (de) Verfahren und kits zur tumorigenizitätsdiagnose
DE3677563D1 (de) Messvorrichtung zur intrakardialen erfassung der blutsauerstoffsaettigung.
DE3880748D1 (de) Verfahren und vorrichtung zur messung oder bestimmung einer oder mehrerer eigenschaften oder der identitaet einer probe.
DE3685584D1 (de) Vorrichtung zur kontinuierlichen oder diskontinuierlichen verabreichung von insulin in den menschlichen koerper.
DE3875826D1 (de) Methode, vorrichtung und testsatz zur messung der aktivitaet eines gewebeplasminogenaktivators.
DE3750745D1 (de) Verfahren und Gerät zur Messung des systolischen Blutdrucks.
DE3850728D1 (de) Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen.
EP0329458A3 (de) Verfahren und Gerät zur Messung von Analyten
DE3782416D1 (de) Vorrichtung zur messung der konzentrationsveraenderung eines blutpigmentes.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties